Haemonetics | HAE - Gross Profit On Sales



Haemonetics reported $192.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Avanos Medical USD 92.1M 2.3M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Boston Scientific USD 3.42B 228M Jun/2025
Cooper Companies USD 692M 12.9M Jul/2025
Fresenius EUR 1.46B 47M Jun/2025
Fresenius Medical Care EUR 1.22B 31M Jun/2025
Globus Medical USD 1.21B 809.01M Jun/2025
Haemonetics USD 192.24M 806K Jun/2025
Hologic USD 576.6M 15.9M Jun/2025
ICU Medical USD 208.06M 2.04M Jun/2025
Intuitive Surgical USD 1.62B 160.2M Jun/2025
Masimo USD 233.3M 700K Jun/2025
Medtronic USD 5.12B 695M Jul/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Neogen USD 92.85M 17.41M May/2025
Quidel USD 227M 116.3M Jun/2025
ResMed USD 827.92M 61.52M Jun/2025
STAAR Surgical USD 32.8M 4.79M Jun/2025
Steris USD 628M 13.21M Jun/2025
Stryker USD 3.84B 30M Jun/2025
Teleflex USD 431.08M 41.65M Jun/2025
Terumo JPY 145.47B 6.94B Jun/2025
Thermo Fisher Scientific USD 4.05B 260M Jun/2025
US Physical Therapy USD 41.62M 10.56M Jun/2025
Zimmer Biomet Holdings USD 1.32B 34.8M Jun/2025